Nat Simons Merck & Co., Inc. Transaction History

Meritage Group LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $19,684 - $21,140	159 Added 7.45%	2,292 $283,000
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $83,797 - $97,642	-740 Reduced 25.76%	2,133 $281,000
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $287,817 - $313,214	2,873 New	2,873 $313,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

Stay updated on Meritage Group LP and Nat Simons with notifications on news.